毛细胞白血病与妊娠:一项系统综述与文献回顾
该系统综述检索1960年至2025年文献,共纳入15例妊娠期毛细胞白血病病例。80%在妊娠期间首次诊断,中位母亲年龄32岁、中位孕周14周。血小板减少普遍存在,全血细胞减少常见。46%在妊娠期接受治疗,干扰素α和脾切除术为最常见一线选择。未见孕产妇死亡、自然流产或死胎。
要点
- 妊娠期毛细胞白血病极罕见,系统综述共纳入15例报告病例。
- 80%病例在妊娠期首次诊断,中位孕周14周,血小板减少普遍存在。
- 46%妊娠期接受治疗,干扰素α和脾切除术为最常见一线选择。
核心结论
- 当前证据支持经仔细选择的干扰素α、脾切除术或延迟全身治疗为可行策略,可在不损害产科结局的情况下控制毛细胞白血病,但需个体化管理并需要进一步证据。
研究设计与样本
- 系统综述与文献回顾,检索1960年至2025年文献,共纳入15例报告病例。
主要发现
- 80%病例在妊娠期间首次诊断,中位母亲年龄32岁,中位孕周14周。
- 血小板减少普遍存在,全血细胞减少常见。
- 46%患者在妊娠期接受治疗,通常在诊断后3周内。
- 干扰素α和脾切除术为最常见一线选择,聚乙二醇干扰素和利妥昔单抗较少使用。
- 未报告孕产妇死亡、自然流产或死胎;分娩中位孕周37周,53.8%为阴道分娩。
关键数值与推荐
- 约半数患者接受产后治疗,最常用克拉屈滨,文献记录病例中反应良好且生育力保留。
临床怎么用
- 当前证据支持经仔细选择的干扰素α、脾切除术或延迟全身治疗作为可行策略,可控制毛细胞白血病而不损害产科结局,但需个体化管理并需要进一步证据。
局限性
- 需要个体化管理并需要进一步证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hairy cell leukaemia (HCL) in pregnancy is exceptionally uncommon. A systematic review of the literature found 15 reported cases from 1960 to 2025. Eighty percent of cases were first diagnosed during pregnancy at a median maternal age of 32 years and a median gestational age of 14 weeks. Thrombocytopenia was universal and pancytopenia frequent. Forty-six percent of patients received therapy while pregnant, generally within 3 weeks of diagnosis. Interferon-alpha and splenectomy were the most common first-line options; pegylated interferon and rituximab were used less often. No maternal deaths, spontaneous abortions or stillbirths were reported. Median gestational age at delivery was 37 weeks, and 53.8% of births were vaginal. Post-partum therapy was administered in roughly half of the patients, most frequently cladribine, with favourable responses and preserved fertility in documented cases. Overall, current evidence supports carefully selected interferon-alpha, splenectomy or delayed systemic therapy as viable strategies that can control HCL without compromising obstetric outcomes, although individualized management and further evidence is needed.
引用
- Borja-Montes OF, Toro-Pedroza A, Epperla N, et al. Hairy cell leukaemia and pregnancy: A systematic review and review of literature. Br J Haematol. 2025. PMID: 40389354. doi:10.1111/bjh.20174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。